139 related articles for article (PubMed ID: 37797398)
1. Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis.
Yin X; Kan F
Cancer Epidemiol; 2023 Dec; 87():102457. PubMed ID: 37797398
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma.
Song K; Yi J; Shen X; Cai Y
PLoS One; 2012; 7(11):e48924. PubMed ID: 23185284
[TBL] [Abstract][Full Text] [Related]
4. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
Li L; Lan X
J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
[TBL] [Abstract][Full Text] [Related]
5. GSTT1 null genotype contributes to hepatocellular carcinoma risk: a meta-analysis.
Chen KJ; Fan F; Wang Y; Wei GT; Hu L; Xu F
Tumour Biol; 2014 Jan; 35(1):213-8. PubMed ID: 23959468
[TBL] [Abstract][Full Text] [Related]
6. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
[TBL] [Abstract][Full Text] [Related]
7. Tumor Necrosis Factor-Alpha Gene Promoter (TNF-α G-308A) Polymorphisms Increase the Risk of Hepatocellular Carcinoma in Asians: A Meta-Analysis.
Verma HK; Merchant N; Bhaskar LVKS
Crit Rev Oncog; 2020; 25(1):11-20. PubMed ID: 32865907
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: Preliminary Observations.
Amougou Atsama M; Atangana PJA; Noah Noah D; Moundipa PF; Pineau P; Njouom R
Int J Infect Dis; 2017 Nov; 64():4-8. PubMed ID: 28847760
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
11. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk.
Shen YH; Chen S; Peng YF; Shi YH; Huang XW; Yang GH; Ding ZB; Yi Y; Zhou J; Qiu SJ; Fan J; Ren N
Tumour Biol; 2014 May; 35(5):4007-15. PubMed ID: 24399650
[TBL] [Abstract][Full Text] [Related]
13. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
14. Association of the interleukin-28B gene polymorphism with development of hepatitis virus-related hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
Suo GJ; Zhao ZX
Genet Mol Res; 2013 Sep; 12(3):3708-17. PubMed ID: 24085431
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma.
Wong GL; Chan HL; Yiu KK; Lai JW; Chan VK; Cheung KK; Wong EW; Wong VW
Aliment Pharmacol Ther; 2013 Mar; 37(5):517-26. PubMed ID: 23305043
[TBL] [Abstract][Full Text] [Related]
16. Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Liao Y; Hu X; Chen J; Cai B; Tang J; Ying B; Wang H; Wang L
PLoS One; 2012; 7(6):e38394. PubMed ID: 22675557
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis.
Thevathasan T; Colbatzky T; Schmelzle M; Pratschke J; Krenzien F
BMJ Open; 2021 Aug; 11(8):e045733. PubMed ID: 34376442
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-Related 5 Gene rs510432 Polymorphism Is Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Han Q; Lv Y; Liu Z
Immunol Invest; 2019 May; 48(4):378-391. PubMed ID: 30907204
[TBL] [Abstract][Full Text] [Related]
19. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk.
Xue M; Lin X; Lin QX; Pu X; Liu J; Li XF; Hou J; Liu X; Chen R
Int J Cancer; 2021 Jun; 148(12):2974-2981. PubMed ID: 33554326
[TBL] [Abstract][Full Text] [Related]
20. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
